Form 4 for PROK PROKIDNEY CORP.
Accepted 2024-04-17 00:00:00 ET · period of report 2024-04-16 · accession 0000950170-24-045248 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-04-17 | 2024-04-16 | PROK | Weber Darin J. | SVP of Regulatory Development | S - Sale | $2.50 | -17.2K | 172.4K | -9% | -$43.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2024-04-16 | S | D | 17,238 | $2.50 | 172,432 | D | — | — | (F1) The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023. |